...
首页> 外文期刊>Journal of biomaterials science >In vitro degradation and drug-release properties of water-soluble chitosan cross-linked oxidized sodium alginate core-shell microgels
【24h】

In vitro degradation and drug-release properties of water-soluble chitosan cross-linked oxidized sodium alginate core-shell microgels

机译:水溶性壳聚糖交联氧化海藻酸钠核壳微凝胶的体外降解及释药性能

获取原文
获取原文并翻译 | 示例
           

摘要

Hydrogels based on sodium alginate (SA) have already been widely used in biomedical applications using Ca ~(2+) as a cross-linker; however, these hydrogels tend to disintegrate in electrolyte solutions. To solve this problem, we present a kind of oxidized sodium alginate (OSA) microgel using water-soluble chitosan (WSC) as a cross-linker. This microgel was successfully prepared via an emulsion cross-linking technique at room temperature. The microgel was cross-linked by the formation of both Schiff base bonds and inter- polyelectrolyte complexes, which can efficiently eliminate the disintegration of the microgel in electrolyte solutions. Morphological properties of the resulting microgels were determined by transmission electron microscopy (TEM), hydrodynamic diameters of the microgels were characterized by dynamic light scattering (DLS). The objective of this work was to achieve the colon-specific delivery of an anti-ulcerative colitis drug. 5-Aminosalicylic acid (5-ASA) was chosen as a model drug and the in vitro drug-release profile was established in buffer solutions with 0.1 M HCl/NaCl (pH 1.2) and 0.1 M phosphate-buffered saline (PBS, pH 7.4) at 37°C. The microgel was incubated in 0.1 M PBS (pH 7.4) at 37°C to determine its degradation behavior. Cell cytotoxicity (tested by MTT assay) showed that this microgel had no significant cytotoxicity. These results indicated that this microgel prepared by introducing WSC into OSA may have potential applications in oral controlled drug-delivery systems. Therefore, the OSA/WSC microgel may be a useful carrier for the colon-specific delivery of anti-inflammatory drugs including 5-ASA and the enhanced therapeutic effect of ulcerative colitis.
机译:基于海藻酸钠(SA)的水凝胶已经广泛用于使用Ca〜(2+)作为交联剂的生物医学应用中。然而,这些水凝胶倾向于在电解质溶液中崩解。为了解决这个问题,我们提出了一种使用水溶性壳聚糖(WSC)作为交联剂的氧化海藻酸钠(OSA)微凝胶。该微凝胶是在室温下通过乳液交联技术成功制备的。通过形成席夫碱键和聚电解质间复合物使微凝胶交联,这可以有效消除电解质溶液中微凝胶的崩解。通过透射电子显微镜(TEM)确定所得微凝胶的形态学性质,通过动态光散射(DLS)表征微凝胶的流体动力学直径。这项工作的目的是实现抗溃疡性结肠炎药物的结肠特异性递送。选择5-氨基水杨酸(5-ASA)作为模型药物,并在含0.1 M HCl / NaCl(pH 1.2)和0.1 M磷酸盐缓冲盐水(PBS,pH 7.4)的缓冲溶液中建立了体外药物释放曲线)在37°C下。将微凝胶在37°C的0.1 M PBS(pH 7.4)中孵育,以确定其降解行为。细胞的细胞毒性(通过MTT分析测试)表明该微凝胶没有明显的细胞毒性。这些结果表明,通过将WSC引入OSA中制备的这种微凝胶在口服控制的药物递送系统中可能具有潜在的应用。因此,OSA / WSC微凝胶可能是用于结肠特异性递送抗炎药(包括5-ASA)和溃疡性结肠炎的增强治疗效果的有用载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号